Finalizing display...
Ligand source activities (1 row/activity)
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
CHEMBL31344 | 106181 | None | 49 | Human | Binding | Ki | = | 2320.00 | 5.63 | - | 3 | Displacement of [3H]PSB-12150 from human GPR17 expressed in CHO-K1 cell membranes after 60 mins by competition binding assay | ChEMBL | 301.0 | 4 | 3 | 2 | 3.19 | O=C(O)CCc1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12 | https://dx.doi.org/10.1021/ml400399f | |
CHEMBL31344 | 106181 | None | 49 | Human | Binding | Ki | = | 1210.00 | 5.92 | - | 3 | Displacement of [3H]PSB-12150 from human GPR17 expressed in CHO-K1 cell membranes after 60 mins by homologous competition binding assay in presence of pranlukast | ChEMBL | 301.0 | 4 | 3 | 2 | 3.19 | O=C(O)CCc1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12 | https://dx.doi.org/10.1021/ml400399f | |
CHEMBL31344 | 106181 | None | 49 | Human | Binding | Ki | = | 2450.00 | 5.61 | - | 3 | Displacement of [3H]PSB-12150 from human GPR17 expressed in CHO cell membranes after 60 mins by liquid scintillation counting | ChEMBL | 301.0 | 4 | 3 | 2 | 3.19 | O=C(O)CCc1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12 | https://dx.doi.org/10.1021/acs.jmedchem.7b01768 | |
CHEMBL31344 | 106181 | None | 49 | Human | Binding | Kd | = | 1256.00 | 5.90 | - | 3 | Binding affinity to human GPR17 expressed in CHO-K1 cell membranes after 60 mins by saturation curve study | ChEMBL | 301.0 | 4 | 3 | 2 | 3.19 | O=C(O)CCc1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12 | https://dx.doi.org/10.1021/ml400399f | |
CHEMBL4206497 | 163940 | None | 0 | Human | Binding | Ki | = | 1500.00 | 5.82 | - | 2 | Displacement of [3H]PSB-12150 from human GPR17 expressed in CHO cell membranes after 60 mins by liquid scintillation counting | ChEMBL | 333.2 | 10 | 3 | 3 | 3.84 | CCCCCCOc1ccc2c(CCC(=O)O)c(C(=O)O)[nH]c2c1 | https://dx.doi.org/10.1021/acs.jmedchem.7b01768 | |
CHEMBL4215280 | 164660 | None | 0 | Human | Binding | Ki | = | 13100.00 | 4.88 | - | 3 | Displacement of [3H]PSB-12150 from human GPR17 expressed in CHO cell membranes after 60 mins by liquid scintillation counting | ChEMBL | 367.1 | 10 | 3 | 3 | 4.50 | CCCCCCOc1cc(Cl)c2c(CCC(=O)O)c(C(=O)O)[nH]c2c1 | https://dx.doi.org/10.1021/acs.jmedchem.7b01768 | |
GAVESTINEL | 172551 | None | 21 | Human | Binding | Ki | = | 1630.00 | 5.79 | - | 2 | Displacement of [3H]PSB-12150 from human GPR17 expressed in CHO-K1 cell membranes after 60 mins by heterologous competition binding assay | ChEMBL | 374.0 | 4 | 3 | 2 | 4.83 | O=C(/C=C/c1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12)Nc1ccccc1 | https://dx.doi.org/10.1021/ml400399f | |
montelukast | 2592 | None | 44 | Human | Binding | pKi | = | 5.18 | 8.29 | -87 | 21 | Displacement of [3H]PSB-12150 from human GPR17 expressed in CHO-K1 cell membranes after 60 mins by heterologous competition binding assay | Drug Central | 585.2 | 12 | 2 | 4 | 8.95 | CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1 | - | |
montelukast | 2592 | None | 44 | Human | Binding | Ki | = | 6540.00 | 5.18 | -87 | 21 | Displacement of [3H]PSB-12150 from human GPR17 expressed in CHO-K1 cell membranes after 60 mins by heterologous competition binding assay | ChEMBL | 585.2 | 12 | 2 | 4 | 8.95 | CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1 | https://dx.doi.org/10.1021/ml400399f | |
pranlukast | 3162 | None | 53 | Human | Binding | Ki | = | 4060.00 | 5.39 | -54 | 11 | Displacement of [3H]PSB-12150 from human GPR17 expressed in CHO-K1 cell membranes after 60 mins by heterologous competition binding assay | ChEMBL | 481.2 | 9 | 2 | 7 | 4.63 | O=C(Nc1cccc2c(=O)cc(-c3nnn[nH]3)oc12)c1ccc(OCCCCc2ccccc2)cc1 | https://dx.doi.org/10.1021/ml400399f | |
pranlukast | 3162 | None | 53 | Human | Binding | pKi | = | 5.39 | 8.27 | -54 | 11 | Displacement of [3H]PSB-12150 from human GPR17 expressed in CHO-K1 cell membranes after 60 mins by heterologous competition binding assay | Drug Central | 481.2 | 9 | 2 | 7 | 4.63 | O=C(Nc1cccc2c(=O)cc(-c3nnn[nH]3)oc12)c1ccc(OCCCCc2ccccc2)cc1 | - |
Showing 1 to 11 of 11 entries
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
ASN02563583 | 497 | None | 0 | Human | Functional | pEC50 | = | - | 9.96 | - | 1 | Unclassified | Guide to Pharmacology | 460.2 | 8 | 1 | 7 | 5.07 | COc1ccc(-n2c(SC(C)C(=O)Nc3ccccc3)nnc2-c2ccccc2OC)cc1 | https://pubmed.ncbi.nlm.nih.gov/21744154 | |
ASN04421891 | 498 | None | 0 | Human | Functional | pEC50 | = | - | 8.44 | - | 1 | Unclassified | Guide to Pharmacology | 524.3 | 12 | 1 | 8 | 4.00 | COCCn1nnnc1C(c1cc2cc(OC)ccc2[nH]c1=O)N(CCc1ccccc1)Cc1ccccc1 | https://pubmed.ncbi.nlm.nih.gov/21744154 | |
ASN04450772 | 499 | None | 0 | Human | Functional | pEC50 | = | - | 8.93 | - | 1 | Unclassified | Guide to Pharmacology | 535.2 | 10 | 4 | 9 | 2.83 | COc1ccc(CNC(=O)C(c2ccc(O)cc2)N(Cc2ccco2)C(=O)c2snc(C(N)=O)c2N)cc1 | https://pubmed.ncbi.nlm.nih.gov/21744154 | |
ASN04885796 | 500 | None | 0 | Human | Functional | pEC50 | = | - | 9.96 | - | 1 | Unclassified | Guide to Pharmacology | 517.2 | 9 | 1 | 7 | 3.65 | COc1ccc(N(C(=O)Cn2nnc3ccccc32)C(C(=O)NCC2CCCO2)c2ccc(F)cc2)cc1 | https://pubmed.ncbi.nlm.nih.gov/21744154 | |
ASN06917370 | 501 | None | 0 | Human | Functional | pEC50 | = | - | 9.57 | - | 1 | Unclassified | Guide to Pharmacology | 531.1 | 4 | 2 | 6 | 4.65 | O=C(Nc1ccc(C(F)(F)F)cc1)N1CCC(c2nc(=O)c3nnn(Cc4ccccc4Cl)c3[nH]2)CC1 | https://pubmed.ncbi.nlm.nih.gov/21744154 | |
ATP | 520 | None | 42 | Human | Functional | pEC50 | = | - | 7.43 | 3 | 10 | Unclassified | Guide to Pharmacology | 507.0 | 8 | 7 | 14 | -1.63 | Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O | https://pubmed.ncbi.nlm.nih.gov/21773766 | |
ATP | 520 | None | 42 | Human | Functional | pEC50 | = | 7.43 | 8.13 | 3 | 10 | None | Drug Central | 507.0 | 8 | 7 | 14 | -1.63 | Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O | - | |
cangrelor | 787 | None | 27 | Human | Functional | IC50 | = | 0.70 | 9.15 | 2 | 4 | Antagonist activity at human GPR17 expressed in human 1321N1 cells assessed as inhibition of UDP-glucose-induced [35S]GTPgammaS binding after 30 mins by rapid filtration assay | ChEMBL | 774.9 | 15 | 7 | 15 | 2.85 | CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O)[C@@H](O)[C@H]1O | https://dx.doi.org/10.1021/jm901691y | |
cangrelor | 787 | None | 27 | Mouse | Functional | pIC50 | = | - | 8.92 | -4 | 4 | Unclassified | Guide to Pharmacology | 774.9 | 15 | 7 | 15 | 2.85 | CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O)[C@@H](O)[C@H]1O | https://pubmed.ncbi.nlm.nih.gov/18974869 | |
cangrelor | 787 | None | 27 | Mouse | Functional | pIC50 | = | 8.92 | 8.05 | -4 | 4 | None | Drug Central | 774.9 | 15 | 7 | 15 | 2.85 | CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O)[C@@H](O)[C@H]1O | - | |
CHEMBL1199042 | 14225 | None | 5 | Human | Functional | IC50 | = | 112.00 | 6.95 | 169 | 2 | Antagonist activity at human GPR17 expressed in human 1321N1 cells assessed as inhibition of UDP-glucose-induced [35S]GTPgammaS binding after 30 mins by rapid filtration assay | ChEMBL | 521.0 | 9 | 7 | 14 | -1.17 | CNc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O | https://dx.doi.org/10.1021/jm901691y | |
CHEMBL1199057 | 14226 | None | 0 | Human | Functional | IC50 | = | 582.00 | 6.24 | 1 | 2 | Antagonist activity at human GPR17 expressed in human 1321N1 cells assessed as inhibition of UDP-glucose-induced [35S]GTPgammaS binding after 30 mins by rapid filtration assay | ChEMBL | 445.0 | 6 | 5 | 10 | -0.06 | Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@@H](COP(=O)(O)O)O1 | https://dx.doi.org/10.1021/jm901691y | |
CHEMBL1199118 | 14230 | None | 0 | Human | Functional | EC50 | = | 1.40 | 8.85 | - | 1 | Agonist activity at human GPR17 expressed in human 1321N1 cells assessed as induction of [35S]GTPgammaS binding after 30 mins by rapid filtration assay | ChEMBL | 575.1 | 10 | 7 | 14 | 0.14 | O=P(O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O | https://dx.doi.org/10.1021/jm901691y | |
CHEMBL1199140 | 14232 | None | 2 | Human | Functional | EC50 | = | 0.04 | 10.44 | - | 1 | Agonist activity at human GPR17 expressed in human 1321N1 cells assessed as induction of [35S]GTPgammaS binding after 30 mins by rapid filtration assay | ChEMBL | 607.0 | 8 | 7 | 14 | -0.23 | Nc1nc(C#Cc2ccccc2)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O | https://dx.doi.org/10.1021/jm901691y | |
CHEMBL1199150 | 14234 | None | 0 | Human | Functional | EC50 | = | 1.70 | 8.77 | - | 1 | Agonist activity at human GPR17 expressed in human 1321N1 cells assessed as induction of [35S]GTPgammaS binding after 30 mins by rapid filtration assay | ChEMBL | 554.0 | 9 | 7 | 13 | 0.09 | CNc1nc(Cl)cc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O | https://dx.doi.org/10.1021/jm901691y | |
CHEMBL1199366 | 14246 | None | 0 | Human | Functional | EC50 | = | 11.00 | 7.96 | - | 1 | Agonist activity at human GPR17 expressed in human 1321N1 cells assessed as induction of [35S]GTPgammaS binding after 30 mins by rapid filtration assay | ChEMBL | 555.0 | 9 | 7 | 14 | -0.52 | CNc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O | https://dx.doi.org/10.1021/jm901691y | |
CHEMBL129841 | 19482 | None | 17 | Human | Functional | IC50 | = | 508.00 | 6.29 | -1 | 3 | Antagonist activity at human GPR17 expressed in human 1321N1 cells assessed as inhibition of UDP-glucose-induced [35S]GTPgammaS binding after 30 mins by rapid filtration assay | ChEMBL | 425.1 | 7 | 5 | 10 | -0.26 | CNc1ncnc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@@H](COP(=O)(O)O)O1 | https://dx.doi.org/10.1021/jm901691y | |
CHEMBL295718 | 101249 | None | 4 | Human | Functional | EC50 | = | 3715.35 | 5.43 | - | 1 | Agonist activity at recombinant human GPR17 short isoform transfected in human 1321N1 cells assessed as mobilization of intracellular Ca2+ after 20 mins by oregon green 488 BAPTA-1/AM dye-based fluorescence assay | ChEMBL | 267.0 | 4 | 3 | 2 | 2.54 | O=C(O)CCc1c(C(=O)O)[nH]c2cc(Cl)ccc12 | - | |
CHEMBL295718 | 101249 | None | 4 | Human | Functional | EC50 | = | 20.42 | 7.69 | - | 1 | Agonist activity at recombinant human GPR17 short isoform transfected in CHO cells assessed as mobilization of intracellular Ca2+ after 20 mins by oregon green 488 BAPTA-1/AM dye-based fluorescence assay | ChEMBL | 267.0 | 4 | 3 | 2 | 2.54 | O=C(O)CCc1c(C(=O)O)[nH]c2cc(Cl)ccc12 | - | |
CHEMBL295718 | 101249 | None | 4 | Human | Functional | EC50 | = | 3720.00 | 5.43 | - | 1 | Agonist activity at human GPR17 expressed in human 1321N1 cells assessed as induction of calcium mobilization after 1 hr by Oregon Green BAPTA-1/AM dye-based fluorescence assay | ChEMBL | 267.0 | 4 | 3 | 2 | 2.54 | O=C(O)CCc1c(C(=O)O)[nH]c2cc(Cl)ccc12 | https://dx.doi.org/10.1021/acs.jmedchem.7b01768 |
Showing 1 to 20 of 126 entries